SEC Probes CMS In Stock Info Leak Investigation
The U.S. Securities and Exchange Commission is investigating whether employees of the Centers for Medicare and Medicaid Services leaked information about a prostate cancer drug to Wall Street traders that profited...To view the full article, register now.
Already a subscriber? Click here to view full article